FDA Inspection 1027866 — Marco Antonio Alvarez Gonzalez, MD, PhD
The FDA completed an inspection of Marco Antonio Alvarez Gonzalez, MD, PhD on September 15, 2017 in Barcelona. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 15, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Barcelona (Spain)
Additional Details
Clinical Investigator (CI)